Correlation of Thymic Pathology with HLA in Myasthenia Gravis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (16)
CLINICAL, PATHOLOGICAL, HLA ANTIGEN AND IMMUNOLOGICAL EVIDENCE FOR DISEASE HETEROGENEITY IN MYASTHENIA GRAVIS
1980 • 465 citations
HLA‐DR, DO AND DP TYPING USING PCR AMPLIFICATION AND IMMOBILIZED PROBES
1991 • 197 citations
Multivariate Interpretation of Clinical Laboratory Data.
1988 • 140 citations
Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis.
1996 • 110 citations
Long-Term Outcome and Quality of Life After Thymectomy for Myasthenia Gravis
1996 • 98 citations
A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes.
1998 • 75 citations
Identification of genomic typing of non-DR3 HLA class II genes associated with myasthenia gravis
1993 • 71 citations
Depletion of CD8+ T cells suppresses the development of experimental autoimmune myasthenia gravis in Lewis rats
1995 • 64 citations
Immunogenetics of experimental autoimmune myasthenia gravis.
1989 • 63 citations
Myasthenia gravis patients with thymus hyperplasia and myasthenia gravis patients with thymoma display different HLA associations
1991 • 49 citations
Exacerbation of myasthenia gravis after removal of thymomas
2009 • 36 citations
Thymoma-associated myasthenia gravis. Transplantation of thymoma and extrathymomal thymic tissue into SCID mice.
1996 • 26 citations
Nomenclature for factors of the HLA system, update March 1995
1995 • 10 citations
A one-step monoclonal antibody typing procedure that simplifies HLA class I and class II typing
1994 • 9 citations
Nomenclature for factors of the HLA system, update March 1995
1995 • 9 citations
The impact of HLA on long-term outcome after thymectomy for myasthenia gravis
1998 • 7 citations
Cited By (0)
No citing papers found in database